AcuSurgical, a French startup developing novel robots and procedures for the retina and ophthalmology surgery markets, announces the appointment of Michael BROWNELL as Chairman of the Board.
Recommended AI News: Analog Devices and Keysight Collaborate to Speed Development of O-RAN Solutions
Michael Brownell is a serial entrepreneur in early-stage companies developing new technology, products, and markets. He has served as VP of Product Development for Intralase, Global Head/VP/Director of surgical equipment for AMO (Advanced/Abbott Medical Optics), CEO of Gobiquity, CTO of PowerLase, and other executive positions, Michael received an MS in Physics, Lasers, and Optics from San Diego State University.
Michael brings to AcuSurgical 30 years of international experience with innovative businesses and new product development in ophthalmology, to help build a great company that is fast to market with high value solutions, and to establish the company as one of the robotic surgery leaders in ophthalmology.
Recommended AI News: Accenture Positioned as a Leader in Digital Strategy Consulting Services by the IDC MarketScape
AcuSurgical CEO Christoph Spuhler says : “Michael’s experience is an excellent fit to help us with our mission to transform ophthalmic surgery and will be a great addition to the board. We’re excited to have him join the team.”
Investors say : Valerie Calenda, Managing Partner at Merieux Equity Partners: «Michael is well complementing the team, bringing a wealth of experience in the global ophthalmology industry and particularly in the development of innovative products.» Celia Hart, General Partner at Supernova Invest: «I am confident his strategic insights will be instrumental to the further development and growth of AcuSurgical»
Recommended AI News: Intel’s Silicon, Software Accelerate 5G, Edge
Comments are closed.